Suppr超能文献

端粒的替代性延长:连接染色体末端的桥梁。

Alternative Lengthening of Telomeres: Building Bridges To Connect Chromosome Ends.

机构信息

Department of Pharmacology and Chemical Biology, Hillman Cancer Center, University of Pittsburgh School of Medicine (UPMC), Pittsburgh, PA, USA.

Department of Pharmacology and Chemical Biology, Hillman Cancer Center, University of Pittsburgh School of Medicine (UPMC), Pittsburgh, PA, USA.

出版信息

Trends Cancer. 2020 Mar;6(3):247-260. doi: 10.1016/j.trecan.2019.12.009. Epub 2020 Jan 23.

Abstract

Alternative lengthening of telomeres (ALT) is a mechanism of telomere maintenance that is observed in many of the most recalcitrant cancer subtypes. Telomeres in ALT cancer cells exhibit a distinctive nucleoprotein architecture shaped by the mismanagement of chromatin that fosters cycles of DNA damage and replicative stress that activate homology-directed repair (HDR). Mutations in specific chromatin-remodeling factors appear to be key determinants of the emergence and survival of ALT cancer cells. However, these may represent vulnerabilities for the targeted elimination of ALT cancer cells that infiltrate tissues and organs to become devastating tumors. In this review we examine recent findings that provide new insights into the factors and mechanisms that mediate telomere length maintenance and survival of ALT cancer cells.

摘要

端粒的非经典延长(ALT)是端粒维持的一种机制,在许多最顽固的癌症亚型中都有观察到。ALT 癌细胞中的端粒表现出独特的核蛋白结构,这种结构是由染色质的错误管理形成的,促进了 DNA 损伤和复制应激的循环,从而激活同源重组修复(HDR)。特定染色质重塑因子的突变似乎是 ALT 癌细胞出现和存活的关键决定因素。然而,这些可能代表着靶向消除浸润组织和器官并成为致命肿瘤的 ALT 癌细胞的脆弱性。在这篇综述中,我们研究了最近的发现,这些发现为介导端粒长度维持和 ALT 癌细胞存活的因素和机制提供了新的见解。

相似文献

1
Alternative Lengthening of Telomeres: Building Bridges To Connect Chromosome Ends.
Trends Cancer. 2020 Mar;6(3):247-260. doi: 10.1016/j.trecan.2019.12.009. Epub 2020 Jan 23.
3
Life and cancer without telomerase: ALT and other strategies for making sure ends (don't) meet.
Crit Rev Biochem Mol Biol. 2017 Feb;52(1):57-73. doi: 10.1080/10409238.2016.1260090. Epub 2016 Nov 28.
4
Alternative Lengthening of Telomeres: DNA Repair Pathways Converge.
Trends Genet. 2017 Dec;33(12):921-932. doi: 10.1016/j.tig.2017.09.003. Epub 2017 Sep 29.
5
The macroH2A1.2 histone variant links ATRX loss to alternative telomere lengthening.
Nat Struct Mol Biol. 2019 Mar;26(3):213-219. doi: 10.1038/s41594-019-0192-3. Epub 2019 Mar 4.
7
Telomeric replication stress: the beginning and the end for alternative lengthening of telomeres cancers.
Open Biol. 2022 Mar;12(3):220011. doi: 10.1098/rsob.220011. Epub 2022 Mar 9.
9
ATRX affects the repair of telomeric DSBs by promoting cohesion and a DAXX-dependent activity.
PLoS Biol. 2020 Jan 2;18(1):e3000594. doi: 10.1371/journal.pbio.3000594. eCollection 2020 Jan.
10
Alternative mechanisms of telomere lengthening: permissive mutations, DNA repair proteins and tumorigenic progression.
Mutat Res. 2013 Mar-Apr;743-744:142-150. doi: 10.1016/j.mrfmmm.2012.11.006. Epub 2012 Dec 3.

引用本文的文献

1
Atypical R-loops in cancer: decoding molecular chaos for therapeutic gain.
J Transl Med. 2025 Aug 14;23(1):912. doi: 10.1186/s12967-025-06929-x.
3
Alternative Lengthening of Telomeres: The Need for Mutations Is Lineage-Dependent.
Int J Mol Sci. 2025 Jul 15;26(14):6765. doi: 10.3390/ijms26146765.
4
Combined inhibition of de novo glutathione and nucleotide biosynthesis is synthetically lethal in glioblastoma.
Cell Rep. 2025 May 27;44(5):115596. doi: 10.1016/j.celrep.2025.115596. Epub 2025 Apr 19.
5
Mechanisms and molecular characterization of relapsed/refractory neuroblastomas.
Front Oncol. 2025 Mar 6;15:1555419. doi: 10.3389/fonc.2025.1555419. eCollection 2025.
8
Locking the gates of immortality: targeting alternative lengthening of telomeres (ALT) pathways.
Med Oncol. 2025 Feb 18;42(3):78. doi: 10.1007/s12032-025-02627-2.
9
CHROMOPHOBE HEPATOCELLULAR CARCINOMA: DIAGNOSTIC CHALLENGES.
Arq Bras Cir Dig. 2025 Jan 20;37:e1863. doi: 10.1590/0102-6720202400069e1863. eCollection 2025.
10
The single-stranded DNA-binding factor SUB1/PC4 alleviates replication stress at telomeres and is a vulnerability of ALT cancer cells.
Proc Natl Acad Sci U S A. 2025 Jan 14;122(2):e2419712122. doi: 10.1073/pnas.2419712122. Epub 2025 Jan 7.

本文引用的文献

1
Nuclear receptors regulate alternative lengthening of telomeres through a novel noncanonical FANCD2 pathway.
Sci Adv. 2019 Oct 9;5(10):eaax6366. doi: 10.1126/sciadv.aax6366. eCollection 2019 Oct.
2
Rad52 Restrains Resection at DNA Double-Strand Break Ends in Yeast.
Mol Cell. 2019 Dec 5;76(5):699-711.e6. doi: 10.1016/j.molcel.2019.08.017. Epub 2019 Sep 18.
4
SLX4IP Antagonizes Promiscuous BLM Activity during ALT Maintenance.
Mol Cell. 2019 Oct 3;76(1):27-43.e11. doi: 10.1016/j.molcel.2019.07.010. Epub 2019 Aug 22.
5
RAD51AP1 Is an Essential Mediator of Alternative Lengthening of Telomeres.
Mol Cell. 2019 Oct 3;76(1):11-26.e7. doi: 10.1016/j.molcel.2019.06.043. Epub 2019 Aug 7.
6
TSPYL5 Depletion Induces Specific Death of ALT Cells through USP7-Dependent Proteasomal Degradation of POT1.
Mol Cell. 2019 Aug 8;75(3):469-482.e6. doi: 10.1016/j.molcel.2019.05.027. Epub 2019 Jul 2.
7
Clustered telomeres in phase-separated nuclear condensates engage mitotic DNA synthesis through BLM and RAD52.
Genes Dev. 2019 Jul 1;33(13-14):814-827. doi: 10.1101/gad.324905.119. Epub 2019 Jun 6.
8
The FANCM-BLM-TOP3A-RMI complex suppresses alternative lengthening of telomeres (ALT).
Nat Commun. 2019 May 28;10(1):2252. doi: 10.1038/s41467-019-10180-6.
10
Rad52 prevents excessive replication fork reversal and protects from nascent strand degradation.
Nat Commun. 2019 Mar 29;10(1):1412. doi: 10.1038/s41467-019-09196-9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验